Your session is about to expire
← Back to Search
Young Adult Heavy Drinkers Group 1 for Alcoholism (IDEA Trial)
IDEA Trial Summary
This trial will test whether different aspects of impulsivity are related to how enjoyable and sedating someone finds alcohol.
- Alcoholism
- Alcohol Sensitivity
IDEA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IDEA Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What purpose does Young Adult Heavy Drinkers Group 1 typically serve?
"Young Adult Heavy Drinkers Group 1 can be employed to treat obstruction hypertrophic cardiomyopathy, contagious illnesses, and ethylene glycol toxicity."
Is this study recruiting individuals aged 50 and over?
"Eligible participants must be aged between 21 to 30 years old. Alternatively, there are 26 studies open for those under 18 and 212 trials available for seniors over the age of 65."
What criteria must be met to qualify a candidate for this research endeavor?
"To qualify for this trial, applicants must have a recent history of using ethanol and be between the age brackets of 21 and 30. At present, there are still 30 positions available to prospective participants."
What is the current population of participants in this research?
"This clinical trial is now closed, having been initially posted on May 1st 2019 and updated for the last time on October 11th 2022. For anyone searching for alternative studies, there are currently 268 trials recruiting patients with ethanol exposure and 38 trials looking specifically to admit Young Adult Heavy Drinkers Group 1 participants."
Is this research opportunity still open for enrollment?
"This trial is no longer open for recruitment. It was initially posted on May 1st 2019 and concluded its updates with a post from October 11th 2022. Alternatively, there are currently 268 trials recruiting participants to trial ethanol while 38 studies are actively looking for Young Adult Heavy Drinkers Group 1 members."
Share this study with friends
Copy Link
Messenger